15.1 C
New York
Friday, September 29, 2023

Eiger BioPharmaceuticals Inc. (NASDAQ: EIGR) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Eiger BioPharmaceuticals Inc. (EIGR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 4.88%, to $0.43. The Eiger BioPharmaceuticals Inc. has recorded 16,980 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Eiger BioPharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Eiger BioPharmaceuticals Inc. is $20.41M. A total of 3.51 million shares were traded on the day, compared to an average of 444.12K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, EIGR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 2 BUYs and 4 SELLs from insiders. Insiders purchased 150,000 shares during that period but sold 31,895.

In the most recent transaction, Mayer Eldon C. III sold 4,395 shares of EIGR for 1.07 per share on Mar 17. After the transaction, the Ex VP & Chief Commerc. Officer now owns 56,073 company shares. In a previous transaction on Jan 23, Dietz Thomas John bought 50,000 shares at 1.43 per share. EIGR shares that Director owns now total 50,000.

Among the insiders who sold shares, Murray Christine disposed of 5,000 shares on Dec 29 at a per-share price of $1.22. This resulted in the Director holding 11,000 shares of EIGR after the transaction. In another insider transaction, Glenn Jeffrey S bought 100,000 shares at $1.28 per share on Dec 22. Company shares held by the Director now total 182,355.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for EIGR in the last 3 months, the mean price target is $3.00 with high estimates of $5.00 and low estimates of $1.00. In terms of 52-week highs and lows, EIGR has a high of $8.35 and a low of $0.53.

As of this writing, EIGR has an earnings estimate of -$0.29 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.36. The company reported an EPS of -$0.52 in the last quarter, which was -10.60% lower than expectations of -$0.47.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EIGR’s latest balance sheet shows that the firm has $88.81M in Cash & Short Term Investments as of fiscal 2021. There were $32.54M in debt and $29.90M in liabilities at the time. Its Book Value Per Share was $0.35, while its Total Shareholder’s Equity was $72.40M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EIGR is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles